Artificial Epidemics: How Medical Activism Has Inflated the Diagnosis of Prostate Cancer and Depression (Kindle Single)
Artificial Epidemics: How Medical Activism Has Inflated the Diagnosis of Prostate Cancer and Depression (Kindle Single)
by Stewart Justman
Dr. Patrick Walsh's Guide to Surviving Prostate Cancer, Second Edition
Dr. Patrick Walsh's Guide to Surviving Prostate Cancer, Second Edition
by Patrick C. Walsh Janet Farrar Worthington
Our Price: $11.55
Used from: $2.64

Dr. Patrick Walsh's Guide to Surviving Prostate Cancer
Dr. Patrick Walsh's Guide to Surviving Prostate Cancer
by Patrick C. Walsh Janet Farrar Worthington
Our Price: $12.78
Used from: $12.78

The Decision: Your prostate biopsy shows cancer. Now what?: Medical insight, personal stories, and humor by a urologist who has been where you are now.
The Decision: Your prostate biopsy shows cancer. Now what?: Medical insight, personal stories, and humor by a urologist who has been where you are now.
by John C. McHugh M.D.
Our Price: $13.24
Used from: $9.49

You Can Beat Prostate Cancer: And You Don't Need Surgery to Do It
You Can Beat Prostate Cancer: And You Don't Need Surgery to Do It
by Robert J. Marckini
Our Price: $20.00
Used from: $4.19



Stage 4 Prostate Cancer Links


<< 1 2 3 >>




Stage 4 Prostate Cancer Headlines


US panel recommends against PSA tests for screening prostate cancer in men of ... - CBS News


CBS News

US panel recommends against PSA tests for screening prostate cancer in men of ...
CBS News
(CBS News) Should adult men get a PSA blood test to screen for prostate cancer? In its final recommendation on the subject, the US Preventive Services Task Force has reviewed the evidence and says no, the small benefit from the blood test does not ...
PSA screening for prostate cancer gets thumbs-down from federal panelBoston.com
Prostate-Cancer Test Not Worth Risk, Panel SaysBusinessWeek
AUA Disputes Panel's Recommendations On Prostate Cancer ScreeningMarketWatch (press release)
Boston Globe -Plain Dealer
all 297 news articles »

Read more...


The Megrahi Prognosis - Wall Street Journal


BBC News

The Megrahi Prognosis
Wall Street Journal
Karol Sikora, a leading cancer specialist who examined Megrahi shortly before his release, explains that predicting how long a patient with end-stage prostate cancer has to live is "a value judgment of probability," not an exact science.
Why Lockerbie bomber survived so long with cancerBBC News
Convicted Lockerbie bomber dies of cancer in LibyaWaterloo Cedar Falls Courier

all 3,521 news articles »

Read more...